User:MathJack13/Brouillon

Scientific contribution
Stefan D. Anker, MD, PhD, FESC, is a Professor of Innovative Clinical Trials (W3) at University Medical Center Göttingen in Germany.

The main focus of the Innovative Clinical Trials department is research in the field of chronic heart failure, including the development and clinical testing of new therapies.

He was previously Professor of Cardiology and Cachexia Research (W2) at Charité Berlin between 2002 and 2014.

He studied medicine at Charité medical school Medical School of the Humboldt-University Berlin, Germany, (1987-1993).

He completed his PhD at the National Heart and Lung Institute of Imperial College London in 1998.

Since then, he has had teaching appointments in several countries (Australia, Italy).

His particular research interests include the pathophysiology and treatment of acute and chronic heart failure, cardiac device therapy,

clinical evaluation of cardiovascular biomarkers, pathophysiology of muscle wasting, cachexia therapy in CHF, ageing, sarcopenia and cancer.

Prof.

Anker is a member and serves on the Boards of several academic organisations. He has authored more than 650 original papers, reviews, and editorials.

Stefan Anker serves on the editorial boards of 5 scientific journals (including European Heart Journal and European Journal of Heart Failure.

He is founding Editor-in-Chief of the Journal of Cachexia, Sarcopenia and Muscle (JCSM, IF 7.88, see www.jcsm.info) and of ESC Heart Failure, which is the first open access heart failure journal.

Stefan Anker has won several prizes (including 2 AHA-YIAs), and has obtained a number of fellowships and grants, including 2 NIH grants (WARCEF trial) 2 EU-FP7, 1 IMI grant & 1 Horizon 2020 grant.

Memberships
Stefan is a member of the German Cardiac Society and of the European Society of Cardiology since 1995.

He is currently Vice President of the European Society of Cardiology (ESC) in charge

of National Cardiac Societies and Communications. He serves in the board of the Heart Failure Association (HFA) of the ESC since 2006.

He was HFA President between 2012 and 2014 and he currently chairs the HFA committee on regulatory affairs.

Stefan Anker is the founding president of the International Society on Sarcopenia, Cachexia and Wasting Disorders (SCWD).